 |
EpiCept Reports First Quarter 2012 Operating and Financial Results
May 9, 2012
|
31.8 KB |
|
| |
CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced operating and financial results for the three months
ended March 31, 201...
|
|
EpiCept to Report First Quarter 2012 Operating and Financial Results on May 9, 2012
May 3, 2012
|
11.9 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that it will host a conference call to discuss first
quarter 2012 operating and financial results on Wednesday, May 9, 2012
at 9:00 a.m. Eastern time. Th...
|
|
EpiCept's AmiKet™ Receives Fast Track Designation from FDA
Apr 10, 2012
|
12.2 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that AmiKet™ (amitriptyline 4%, ketamine 2% cream) has
been granted Fast Track designation by the U.S. Food and Drug
Administration (FDA). AmiKet&#...
|
|
EpiCept's Licensed Compound EP1013 Identified as a New Drug Candidate for Treatment of Late-Stage Viral Hepatitis
Apr 4, 2012
|
12.7 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that new preclinical research for its apoptosis
inhibitor drug candidate EP1013 (now renamed F573) has concluded that
F573 is a new therapeutic drug cand...
|
|
EpiCept to Raise $1.1 Million in Registered Direct Offering
Mar 29, 2012
|
12.6 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that it has entered into a definitive agreement with a
single life science focused institutional investor for the purchase of
1,065 shares of its new Ser...
|
|
EpiCept Corporation to Present at the BIO-Europe Spring 2012 Event
Mar 14, 2012
|
12.1 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that Jack Talley, President and Chief Executive Officer,
will be presenting at the BIO-Europe Spring 2012 event on Tuesday, March
20, 2012 at 10:15 A...
|
|
EpiCept Reports Fourth Quarter and Full Year 2011 Operating and Financial Results
Feb 29, 2012
|
40.4 KB |
|
| |
CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced operating and financial results for the fourth quarter
and full year ended D...
|
|
EpiCept Corporation to Report Fourth Quarter and Full Year 2011 Operating and Financial Results on February 29, 2012
Feb 23, 2012
|
12.4 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that it will host a conference call to discuss fourth
quarter and full year 2011 operating and financial results on Wednesday,
February 29, 2012 at 9:00 ...
|
|
EpiCept to Raise $2 Million in Registered Direct Offering
Feb 8, 2012
|
12.5 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that it has entered into a definitive agreement with a
single life science focused institutional investor for the purchase of
2,000 shares of its Ser...
|
|
EpiCept to Present at the 14th Annual BIO CEO & Investor Conference
Feb 8, 2012
|
12.0 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that Jack Talley, President and Chief Executive Officer,
will be presenting at the 14th Annual BIO CEO & Investor
Conference on Monday, February 13, 2012...
|
|
EpiCept Files for AmiKet™ Fast Track Designation
Feb 7, 2012
|
14.0 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that it has filed for Fast Track designation for AmiKet™
(amitriptyline 4%, ketamine 2% cream) for the treatment for
chemotherapy-induced periphera...
|
|
EpiCept Corporation Confirms Engagement of SunTrust Robinson Humphrey to Include Evaluation of Potential Sale Transactions
Jan 24, 2012
|
12.7 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today confirmed that its engagement of SunTrust Robinson Humphrey to
assist in exploring strategic alternatives to maximize the commercial
opportunity of AmiKet™ i...
|
|
EpiCept Corporation Receives Finalized FDA Guidance for AmiKet™ Phase III CIPN Program and Regulatory Strategy
Jan 23, 2012
|
15.0 KB |
|
| |
Clear Pathway for NDA Filing Identified; Fast Track Application
Encouraged
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that it received further encouraging guidance for th...
|
|
EpiCept Corporation Engages SunTrust Robinson Humphrey to Advise on Strategy to Maximize AmiKet™ Potential
Jan 9, 2012
|
13.6 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that it has engaged SunTrust Robinson Humphrey to assist
in exploring strategic alternatives to maximize the commercial
opportunity of AmiKet™, the...
|
|
EpiCept to Present at Two Upcoming Industry Conferences
Jan 5, 2012
|
12.7 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that Jack Talley, President and CEO, will be presenting
at two upcoming industry conferences.
The Biotech Showcase 2012 Confe...
|
|
EpiCept Corporation Appoints Alan W. Dunton, M.D. Non-Executive Chairman of the Board
Jan 5, 2012
|
13.5 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that Alan W. Dunton, M.D., has been appointed to the
Company's Board of Directors and named Non-Executive Chairman, effective
immediately. Dr. Dunton rep...
|
|
EpiCept Corporation Receives FDA Permission to Initiate AmiKet™ Phase III Clinical Development
Dec 23, 2011
|
12.8 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that at a meeting earlier this week with the U.S. Food
and Drug Administration (FDA), the Company was granted permission to
initiate immediately the ...
|
|
EpiCept Provides Update on Ceplene® Manufacturing at Ben Venue Laboratories
Dec 21, 2011
|
12.3 KB |
|
| |
Supplies Available for Patients in European Union
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today provided an update on the impact of the quality assurance review
by the European Medicines ...
|
|
EpiCept to Present at the 22nd Annual Wall Street Institutional Investor Conference
Nov 30, 2011
|
11.9 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that Jack Talley, President and Chief Executive Officer,
will be presenting at the 22nd Annual Wall Street
Institutional Investor Conference on Tuesday, ...
|
|
EpiCept to Present at the NYSSA Biotech and Specialty Pharma Conference
Nov 22, 2011
|
12.0 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that Jack Talley, President and Chief Executive Officer,
will be presenting at the New York Society of Security Analysts' (NYSSA)
15th Annual Biotech and...
|
|
|
